Hospital Profile

Cancer Hospital Chinese Academy of Medical Sciences (CAMS), Beijing

If you are considering Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) in Beijing, the important question is not simply whether the hospital is well known.

The more useful question is:
"Does this hospital have the clinical department, treatment pathway, research access, and practical infrastructure that fit my particular cancer case?"

This page is designed to help you answer that question before you contact the hospital or make an international trip.

Last updated: August 2026
Hospital Summary

At a Glance

HospitalCancer Hospital, Chinese Academy of Medical Sciences (CAMS)
CityBeijing, China
Hospital typePublic specialist cancer hospital
Founded1958
National roleSupporting institution of China's National Cancer Center
Clinical focusOncology diagnosis, surgery, medical oncology, radiation oncology, pathology, imaging, interventional care and multidisciplinary cancer treatment
Research roleNational-level cancer clinical research and drug research
Main campus17 Panjiayuan Nanli, Chaoyang District, Beijing
Official websitecicams.ac.cn
Decision pointHospital selection — suitability depends on cancer type, treatment need, records and access requirements
Note: The hospital states that it was established in 1958, became the supporting institution for the National Cancer Center in 2009, and functions as a national-level cancer center integrating clinical care, education, research and prevention. It also reports multiple national key disciplines and national clinical key specialties.
Why CAMS

Why Patients Consider CAMS Beijing

Cancer Hospital CAMS is different from a general hospital because oncology is its central institutional focus.

That matters when a patient needs access to several cancer-specific disciplines around the same case rather than a single isolated procedure.

The hospital's published clinical structure includes:

  • Head and neck surgery
  • Thoracic surgery
  • Hepatobiliary surgery
  • Gastrointestinal and pancreatic surgery
  • Colorectal surgery
  • Breast surgery
  • Urology
  • Gynecologic oncology
  • Neurosurgery
  • Orthopedic oncology
  • Medical oncology
  • Radiation oncology
  • Interventional oncology
  • Endoscopy
  • Anesthesia and intensive care
  • Pathology
  • Imaging
  • Nuclear medicine and PET-CT
  • Molecular and laboratory services
  • Clinical research / GCP services

The breadth of departments is important because many cancer decisions depend on coordination between specialties rather than on one treatment alone.

Fit Assessment

The Decision That Matters: Is CAMS a Good Fit for Your Case?

A hospital's reputation does not automatically make it the right destination for every patient.

CAMS Beijing may be worth investigating when your case requires one or more of the following:

1. A specialist cancer center

If your case requires a dedicated oncology environment with multiple cancer-focused departments, CAMS is structurally different from a general hospital.

2. Complex surgical oncology

The hospital has dedicated surgical departments covering thoracic, gastrointestinal, hepatobiliary, colorectal, breast, gynecologic, urologic, head and neck, neurosurgical and orthopedic oncology.

Its thoracic surgery department, for example, specifically covers lung cancer, esophageal cancer and other thoracic tumors and reports experience with minimally invasive thoracic surgery.

3. Radiation oncology

The radiation oncology department is organized around head-and-neck, thoracic and abdominal cancer groups and combines clinical radiation treatment with radiation physics and radiobiology.

4. Difficult pathology or diagnostic questions

The pathology department includes tissue pathology, cytopathology and molecular pathology and is designated by the hospital as a national clinical pathology key specialty and a center for difficult tumor pathology diagnosis.

5. Clinical research

CAMS has a substantial research infrastructure, including national clinical research roles and a dedicated clinical research environment for evaluating new anticancer drugs and treatment approaches. This can matter when a patient is specifically exploring a clinical-trial pathway.

However, research activity does not mean that a particular patient is eligible for a particular trial. Trial eligibility must be checked against the current study criteria and the patient's clinical records.
Counter-Signal

Who Should Not Choose CAMS Based on Reputation Alone?

This is one of the most important parts of this page.

Do not choose CAMS simply because:

  • it is a nationally recognized cancer institution;
  • it appears high in a hospital ranking;
  • someone online called it the "best" cancer hospital;
  • treatment may appear cheaper than in another country;
  • a particular therapy is mentioned on a website;
  • another patient had a positive experience there.

A hospital-level reputation is not the same as case-level suitability.

You should first establish:

Cancer type → disease stage → pathology → biomarkers → previous treatment → current treatment need → relevant department → available pathway

Only then does hospital selection become meaningful.

Consider Alternatives

When Another Hospital May Be More Practical

CAMS may not be the most practical choice if your priority is mainly:

A highly specialized treatment available elsewhere

If your required therapy is only available through a specific center, trial, technology, or program, compare that pathway directly rather than selecting CAMS because of its overall reputation.

A specific clinical trial

Trial eligibility, recruitment status, location and inclusion/exclusion criteria matter more than the general reputation of the institution.

Convenience of international-patient services

Large public specialist hospitals can offer extensive clinical resources while still requiring patients to navigate registration, departments, documentation, language and payment processes. For international patients, confirm the practical pathway before travelling.

A second opinion rather than immediate treatment

If your immediate goal is only to understand whether the current diagnosis or treatment plan should be reconsidered, remote record review or a second-opinion pathway may be more efficient than travelling immediately.

Clinical Strengths

What CAMS Is Particularly Interesting For

Rather than describing the hospital with a generic list of "advanced treatments," it is more useful to look at the decision categories.

Thoracic cancers

The hospital's thoracic surgery department covers lung cancer, esophageal cancer, thymic and other mediastinal tumors and reports experience in minimally invasive thoracic surgery and combined treatment of locally advanced thoracic cancers.

Useful question before contacting the hospital:
Which thoracic oncology department should review my records, and is my case primarily surgical, systemic-treatment, radiation, or multidisciplinary?

Radiation treatment

The radiation oncology department includes dedicated head-and-neck, thoracic and abdominal groups and integrates clinical treatment with radiation physics and radiobiology.

Useful question:
Which radiation technique is being considered, and why is it appropriate for my tumor location and treatment goal?

Do not select a center simply because it advertises a particular radiation technology.

Pathology and molecular information

For many modern oncology decisions, the question is not only "Where can I receive treatment?"

Do I have enough diagnostic and molecular information to know which treatment pathway should even be considered?

CAMS has dedicated pathology and molecular pathology capabilities.

Before travelling, ask whether your existing pathology material, slides or blocks should be reviewed and whether additional molecular testing may be required.

Clinical trials

The hospital has a long-standing clinical research infrastructure and participates in cancer clinical studies. Public trial registries also show studies associated with Cancer Hospital, Chinese Academy of Medical Sciences.

But "the hospital has clinical trials" is not enough.

For a meaningful trial inquiry, you need to know:

  • What cancer type is being studied?
  • What stage or disease status is required?
  • What previous treatments are allowed?
  • Which biomarkers are required?
  • Is the study recruiting now?
  • Are international patients eligible?
  • What tests must be repeated?
  • What costs are covered by the study?
  • What costs remain the patient's responsibility?
A clinical trial is an eligibility pathway, not a guaranteed treatment option.
Cell Therapy

CAR-T, Cell Therapy and Other Emerging Treatments

CancerCareE does not treat the presence of a technology name on a hospital website as proof that the treatment is appropriate for a patient.

For CAR-T or another cellular therapy, the relevant questions are:

  1. Is the therapy approved, investigational, or trial-based for this indication?
  2. Which cancer types and treatment lines are eligible?
  3. Which antigen or biomarker is required?
  4. Is the program currently enrolling?
  5. Is the product manufactured commercially or under a clinical-study pathway?
  6. What conditioning, monitoring and hospitalization are required?
  7. What happens if the patient develops a serious treatment-related complication?
  8. What follow-up is required after returning home?
These questions are more useful than simply asking: "Does CAMS offer CAR-T?"
Preparation

How International Patients Should Prepare

Do not start with: "How much does cancer treatment cost?"
Start with a structured medical case.

A hospital needs enough information to understand what it is being asked to review.

Prepare These Records

Essential

Pathology report
Pathology slides or tissue information when relevant
Imaging reports
Original imaging files such as DICOM when available
Complete treatment history
Current medications
Recent laboratory results
Current disease status
Previous treatment response or progression

Particularly useful for some cancers

Molecular / genomic testing
Immunohistochemistry
Flow cytometry
Cytogenetics / FISH
Tumor markers
Performance-status information
Operative reports
Previous radiation treatment plans

The exact requirements depend on the cancer type and the question being asked.

Case Summary

The One-Page Case Summary

Before contacting CAMS, prepare a one-page summary:

Patient: Age / sex / country of residence

Diagnosis: Cancer type / subtype / date diagnosed

Stage: Current stage or disease status

Pathology: Key pathology findings

Biomarkers: Relevant molecular or immunohistochemical findings

Treatment received: Surgery / chemotherapy / radiation / immunotherapy / targeted therapy / cellular therapy

Current treatment: What the patient is receiving now

Disease status: Stable / responding / progressing / recurrent, as documented by the treating team

Recent imaging: Date and main finding

Main question:

  • Is surgery still an option?
  • Is a second treatment pathway worth evaluating?
  • Is there a relevant clinical trial?
  • Is radiation appropriate?
  • Does the pathology need review?
  • Is the patient potentially eligible for a cellular-therapy study?

This format gives a hospital a much clearer starting point than a long unstructured collection of medical files.

Before You Travel

Before You Travel: 12 Questions to Ask

Do not book a flight based only on an initial email.

1

Which department will review my case?

2

Has my medical record actually been reviewed?

3

Is the proposed visit an appointment, a preliminary assessment, or confirmation of treatment acceptance?

4

What additional tests or pathology material are required?

5

Do I need to bring original pathology slides or tissue blocks?

6

Which imaging files should I bring?

7

Will tests need to be repeated in Beijing?

8

What is included in the initial hospital visit?

9

What payment or deposit is required?

10

What language support is available for medical communication?

11

Which hospital campus and department should I attend?

12

What is the follow-up plan if treatment is completed and I return home?

These questions can prevent one of the most common problems in international cancer travel: Arriving at a hospital without a clear understanding of what has actually been accepted, reviewed, scheduled or confirmed.
Cost

Cost: What You Should and Should Not Expect

There is no single reliable "CAMS cancer treatment price."

The final cost can depend on:

  • cancer type;
  • stage;
  • treatment pathway;
  • surgery or systemic therapy;
  • radiation requirements;
  • diagnostic testing;
  • pathology review;
  • medications;
  • length of hospitalization;
  • complications;
  • international-patient arrangements;
  • whether treatment is commercial or part of a clinical study.

Therefore, a price found online should be treated as an orientation figure, not a patient-specific quotation.

Before committing to travel, ask for a written breakdown that separates:

Hospital charges + medications + diagnostics + accommodation-related costs + translation/administrative costs + travel + possible additional testing + contingency costs.

Also ask what is not included.

Logistics

International Patient Logistics

Medical suitability is only one part of an international treatment decision.

Medical records

Confirm whether records should be translated and whether original pathology material or imaging files are required.

Registration

Beijing's official health-services guidance lists Cancer Hospital CAMS among the city's tertiary hospitals and provides its appointment and registration routes. The exact process for an international patient should be confirmed directly with the hospital before travel.

Language

Do not assume that English-language administrative support means that every clinical interaction will be available in English. Ask specifically about registration, medical history taking, pathology discussion, treatment consent, inpatient communication, and discharge instructions.

Payment

Confirm accepted payment methods, deposits, insurance arrangements, itemized invoices, refund rules, and whether international insurance is accepted for the planned service.

Follow-up

Ask how medical records, pathology results, imaging and discharge documentation will be provided after treatment. International treatment should be planned with the return journey in mind, not only the arrival.

Location

Location

Cancer Hospital, Chinese Academy of Medical Sciences

17 Panjiayuan Nanli
Chaoyang District
Beijing 100021
China

The hospital's English-language site lists this address and provides its main telephone number as 010-67781331.

Note: Because hospital campuses, departments and appointment procedures can change, verify the exact department and arrival instructions before travelling.
Our Approach

How CancerCareE Approaches This Hospital

CancerCareE does not rank CAMS as universally suitable for cancer patients.

Instead, we look at the patient's position in the decision journey:

Diagnosis → Stage → Biomarkers → Treatment Selection → Hospital Selection → Country Selection → Treatment → Follow-up

A hospital becomes relevant only after the clinical question is clear.

For example:

Lung cancer + surgical question

  • → Review stage, imaging, resectability and previous treatment
  • → Identify the relevant thoracic oncology pathway
  • → Compare appropriate centers
  • → Determine whether CAMS should be contacted

Relapsed lymphoma + cellular therapy question

  • → Review pathology, treatment history, biomarkers and current disease status
  • → Determine which cellular-therapy or clinical-trial pathways may be relevant
  • → Check current eligibility
  • → Then compare hospitals and countries

This is why CancerCareE does not start with the question: "Which hospital is the best?"
We start with: "What decision does this patient need to make?"

Comparison

CAMS vs. a General Hospital: What Actually Changes?

Question Specialist Cancer Hospital General Multispecialty Hospital
Cancer-specific departmentsUsually extensiveDepends on institution
Complex oncology casesOften a major institutional focusVaries
Cancer researchUsually central to missionVaries
Pathology specializationCancer-focused infrastructure may be extensiveVaries
Clinical trialsOften substantialInstitution-dependent
Multidisciplinary cancer pathwaysCommonDepends on cancer program
International patient processMust be verified individuallyMust be verified individually
Suitability for a specific patientDepends on caseDepends on case

The important point is that hospital type narrows the field; it does not make the decision for you.

Referral Quality

What Would Make a CAMS Referral More Meaningful?

A referral or hospital inquiry becomes much more useful when it contains:

A confirmed diagnosis • current disease status • complete treatment history • relevant pathology • recent imaging • biomarker information where relevant • one clearly defined clinical question

That is much more actionable than simply sending:

"Please tell me the treatment and cost."
Final Check

Before You Choose CAMS: A 60-Second Checklist

Clinical fit
Treatment fit
Evidence
Eligibility
Records
Access
Cost
Logistics
Continuity
If several answers are still "no", travelling may be premature.

Frequently Asked Questions

The Bottom Line

Cancer Hospital Chinese Academy of Medical Sciences is a major national-level oncology institution in Beijing with a broad cancer-specific clinical and research structure.

But its institutional reputation does not automatically make it the right hospital for every patient.

For an international patient, the more useful decision is:

What does my case require → which department should review it → what pathway is actually available → what evidence supports that pathway → what does the hospital need from me → and what happens after treatment?

If those questions are answered clearly, hospital selection becomes much more meaningful.

Sources

Sources & Verification

This profile uses information from:

  • Cancer Hospital, Chinese Academy of Medical Sciences official website
  • Beijing Municipal Government health-service information
  • Chinese Clinical Trial Registry (ChiCTR)
  • ClinicalTrials.gov
  • Peer-reviewed / scientific sources where relevant
Note: Hospital information, clinical-trial availability, appointment routes, costs and international-patient procedures can change. Verify current details with the hospital before making treatment or travel decisions.

Last reviewed: August 2026

About CancerCareE

CancerCareE is an independent Oncology Access Intelligence Platform. We help patients understand cancer treatment pathways, compare international access options, organize medical information and make more informed hospital-selection decisions.

We are not a hospital, clinic or medical provider. We do not diagnose, prescribe or determine treatment. Medical decisions remain with licensed physicians and the treating institution.

Start with the decision, not the hospital name.